These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12974433)

  • 1. Management of lupus nephritis.
    George J
    J Assoc Physicians India; 2003 May; 51():489-94. PubMed ID: 12974433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options in lupus nephritis.
    McLigeyo SO
    East Afr Med J; 1998 Oct; 75(10):609-13. PubMed ID: 10065198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus nephritis: classification, clinical features, and treatment.
    Weissleder R; Galarza DA; Garza MA
    Rev Invest Clin; 1987; 39(3):263-76. PubMed ID: 3324251
    [No Abstract]   [Full Text] [Related]  

  • 4. Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis?
    Giannico G; Fogo AB
    Clin J Am Soc Nephrol; 2013 Jan; 8(1):138-45. PubMed ID: 22977215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus nephritis: pathophysiology, diagnosis, and collaborative management.
    Smith DM; Fortune-Faulkner EM; Spurbeck BL
    Nephrol Nurs J; 2000 Apr; 27(2):199-204, 209-11. PubMed ID: 11111547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of nephritis in systemic lupus erythematodes].
    Ligtenberg G; Derksen RH; Berden JH
    Ned Tijdschr Geneeskd; 1996 Sep; 140(39):1941-4. PubMed ID: 8927179
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of lupus nephritis: immunosuppression, general therapy, dialysis and transplantation.
    Clark WF
    Clin Invest Med; 1994 Dec; 17(6):588-601. PubMed ID: 7895423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic deterioration and more flares: the case against azathioprine plus methylprednisolone in the treatment of proliferative lupus nephritis.
    Chan TM
    Arthritis Rheum; 2007 Mar; 56(3):702-4. PubMed ID: 17328038
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lupus patient with nephropathy. Survival is kidney problem].
    MMW Fortschr Med; 2008 Jan; 150(5):17. PubMed ID: 18300547
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lupus nephritis in the middle of the 20th century and in the beginning of 21st century].
    Tareeva IE; Shilov EM; Krasnova TN; Kozlovskaia LV; Shvetsov MIu; Ianushkevich TN; Samokishina NA
    Ter Arkh; 2001; 73(6):5-10. PubMed ID: 11521523
    [No Abstract]   [Full Text] [Related]  

  • 12. Lupus nephritis: an historical perspective 1968-1998.
    Cameron JS
    J Nephrol; 1999; 12 Suppl 2():S29-41. PubMed ID: 10688400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lupus nephritis: facing the era of immunotherapy.
    Aran AA; Putterman C
    Panminerva Med; 2008 Sep; 50(3):235-45. PubMed ID: 18927528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of membranous lupus nephritis: where are we now?
    Beck LH; Salant DJ
    J Am Soc Nephrol; 2009 Apr; 20(4):690-1. PubMed ID: 19279123
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasmapheresis in a case of necessary discontinuation of cyclophosphamide in the treatment of severe lupus nephritis].
    Saracyn M; Korsak J; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):162-4. PubMed ID: 15603328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.
    Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
    Nephrol Dial Transplant; 2008 Sep; 23(9):2768-76. PubMed ID: 18445640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options for resistant lupus nephritis.
    Mok CC
    Semin Arthritis Rheum; 2006 Oct; 36(2):71-81. PubMed ID: 16884971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing C1q nephropathy from lupus nephritis.
    Sharman A; Furness P; Feehally J
    Nephrol Dial Transplant; 2004 Jun; 19(6):1420-6. PubMed ID: 15004260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis and treatment in lupus nephritis: how we can influence the risk for terminal renal failure.
    Fiehn C
    J Rheumatol; 2006 Aug; 33(8):1464-6. PubMed ID: 16881102
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis.
    Elliot V; Cairns T; Cook HT
    Am J Kidney Dis; 2006 Jan; 47(1):184-90. PubMed ID: 16377401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.